Works by Fisk, John D.


Results: 101
    1
    2
    3

    Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis.

    Published in:
    ACR Open Rheumatology, 2021, v. 3, n. 12, p. 889, doi. 10.1002/acr2.11339
    By:
    • Kowalec, Kaarina;
    • Carney, Heather;
    • Patel, Mitulkumar;
    • Hitchon, Carol;
    • Bolton, James M.;
    • Patten, Scott B.;
    • Graff, Lesley A.;
    • Bernstein, Charles N.;
    • Peschken, Christine;
    • Marrie, Ruth Ann;
    • Sareen, Jitender;
    • Singer, Alexander;
    • Lix, Lisa M.;
    • El‐Gabalawy, Renée;
    • Katz, Alan;
    • Fisk, John D.;
    • Berrigan, Lindsay;
    • Marriott, James
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis.

    Published in:
    Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.874724
    By:
    • Marrie, Ruth Ann;
    • Fisk, John D.;
    • Walld, Randy;
    • Bolton, James M.;
    • Sareen, Jitender;
    • Patten, Scott B.;
    • Singer, Alexander;
    • Lix, Lisa M.;
    • Hitchon, Carol A.;
    • El-Gabalawy, Renée;
    • Katz, Alan;
    • Marriott, James J.;
    • Bernstein, Charles N.
    Publication type:
    Article
    10
    11
    12
    13

    A Clinical Decision‐Making Tool to Identify Red Flags for Remote Cognitive Assessment: An Expert Consensus Study from the Canadian Consortium on Neurodegeneration in Aging.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.088902
    By:
    • Friedman, Nathan;
    • Itzhak, Inbal;
    • Desmarais, Philippe;
    • Fisk, John D;
    • Lee, Linda;
    • Henri‐Bhargava, Alexandre;
    • Pettersen, Jacqueline;
    • McLaughlin, Paula M;
    • Ismail, Zahinoor;
    • Khanassov, Vladimir;
    • Freedman, Morris;
    • Chertkow, Howard;
    • Camicioli, Richard;
    • O'Connell, Megan E;
    • Geddes, Maiya R.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-31160-3
    By:
    • Patel, Ronak;
    • Marrie, Ruth Ann;
    • Bernstein, Charles N.;
    • Bolton, James M.;
    • Graff, Lesley A.;
    • Marriott, James J.;
    • Figley, Chase R.;
    • Kornelsen, Jennifer;
    • Mazerolle, Erin L.;
    • Uddin, Md Nasir;
    • Fisk, John D.;
    • Comorbidity and Cognition in Multiple Sclerosis (CCOMS) Study Group;
    • Bolton, James;
    • Graff, Lesley;
    • Mazerolle, Erin;
    • Figley, Teresa D.;
    • Helmick, Carl A.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Fatigue and Comorbidities in Multiple Sclerosis.

    Published in:
    International Journal of MS Care, 2016, v. 18, n. 2, p. 96, doi. 10.7224/1537-2073.2015-070
    By:
    • Fiest, Kirsten M.;
    • Fisk, John D.;
    • Patten, Scott B.;
    • Tremlett, Helen;
    • Wolfson, Christina;
    • Warren, Sharon;
    • McKay, Kyla A.;
    • Berrigan, Lindsay I.;
    • Marrie, Ruth Ann
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50